Development of inhalable formulations of anti-inflammatory drugs to potentially treat smoke inhalation injury in burn victims

International Journal of Pharmaceutics

Volumn 389, Issue 1-2, 2010, Pages 41-52

  Thai, A ^a   Xiao, J ^a   Ammit, A J ^a   Rohanizadeh, R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Aerosols; Controlled delivery; Particle size; Pulmonary drug delivery; Spray drying

Indexed keywords

ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; HEPARIN; LEUCINE; PENTOXIFYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED DRUG RELEASE; CYTOTOXICITY; DISEASE PREDISPOSITION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; HUMAN; HUMAN CELL; LOADING DRUG DOSE; LUNG BURN; NEBULIZATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; TOPOGRAPHY;

ADMINISTRATION, INHALATION; AEROSOLS; ANTI-INFLAMMATORY AGENTS; ANTICOAGULANTS; BURNS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HEPARIN; HUMANS; LEUCINE; LUNG; PARTICLE SIZE; PENTOXIFYLLINE; SMOKE INHALATION INJURY; TISSUE DISTRIBUTION;

EID: 77349120013     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.01.014     Document Type: Article

References (43)

1. Adi H., Traini D., Chan H.K., and Young P.M. The influence of drug morphology on the aerosolisation efficiency of dry powder inhaler formulations. J. Pharm. Sci. 97 (2008) 2780-2788
2. Adi H., Young P.M., Chan H.K., Stewart P., Agus H., and Traini D. Cospray dried antibiotics for dry powder lung delivery. J. Pharm. Sci. 97 (2008) 3356-3366
3. Adi S., Adi H., Tang P., Traini D., Chan H.K., and Young P.M. Micro-particle corrugation, adhesion and inhalation aerosol efficiency. Eur. J. Pharm. Sci. 35 (2008) 12-18
4. Asada M., Takahashi H., Okamoto H., Tanino H., and Danjo K. Theophylline particle design using chitosan by the spray drying. Int. J. Pharm. 270 (2004) 167-174
5. Bendstrup K.E., Chambers C.B., Jensen J.I., and Newhouse M.T. Lung deposition and clearance of inhaled Tc-99m-heparin in healthy volunteers. Am. J. Respir. Crit. Care Med. 160 (1999) 1653-1658
6. Bidani A., Wang C.Z., and Heming T.A. Early effects of smoke inhalation on alveolar macrophage functions. Burns 22 (1996) 101-106
7. Cetin C., Ozyilmaz M., Baycu C., Kose A.A., and Karabagli Y. Effects of rolling inhibition on smoke inhalation injury. Burns 29 (2003) 307-314
8. Chan H.K., and Chew N.Y.K. Novel alternative methods for the delivery of drugs for the treatment of asthma. Adv. Drug Deliv. Rev. 55 (2003) 793-805
9. Chew N.Y.K., and Chan H.K. In vitro aerosol performance and dose uniformity between the Foradile (R) Aerolizer (R) and the Oxis (R) Turbuhaler (R). J. Aerol. Med. 14 (2001) 495-501
10. Chew N.Y.K., Tang P., Chan H.K., and Raper J.A. How much particle surface corrugation is sufficient to improve aerosol performance of powders?. Pharm. Res. 22 (2005) 148-152
11. Cox C.S., Zwischenberger J.B., Traber D.L., Traber L.D., Haque A.K., and Herndon D.N. Heparin improves oxygenation and minimizes barotraumas after severe smoke-inhalation in an ovine model. Surg. Gynecol. Obstet. 176 (1993) 339-349
12. Desai M.H., Mlcak R., Richardson J., Nichols R., and Herndon D.N. Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/acetylcystine therapy. J. Burn Care Rehabil. 19 (1998) 210-212
13. Enkhbaatar P., Cox R.A., Traber L.D., Westphal M., Aimalohi E., Morita N., Prough D.S., Herndon D.N., and Traber D.L. Aerosolized anticoagulants ameliorate acute lung injury in sheep after exposure to burn and smoke inhalation. Crit. Care Med. 35 (2007) 2805-2810
14. Enkhbaatar P., Esechie A., Wang J., Cox R.A., Nakano Y., Hamahata A., Lange M., Traber L.D., Prough D.S., Herndont D.N., and Traber D.L. Combined anticoagulants ameliorate acute lung injury in sheep after burn and smoke inhalation. Clin. Sci. 114 (2008) 321-329
15. Enkhbaatar P., Murakami K., Yu Y.M., Lin F., Cox R., Traber L., Herndon D., and Traber D. l-Arginine attenuates acute lung injury following smoke inhalation. FASEB J. 21 (2007) A9-A19
16. Finlay W.H. The Mechanics of Inhaled Pharmaceutical Aerosols: An Introduction (2001), Academic Press, Edmonton, Canada
17. Herndon D.N., Barrow R.E., Linares H.A., Rutan R.L., Prien T., Traber L.D., and Traber D.L. Inhalation injury in burned patients-effects and treatment. Burns 14 (1988) 349-356
18. Herndon D.N. Inhalation injury. Total Burn Care. 2nd ed. (2002), Elsevier Inc pp. 242-253
19. Holt J., Saffle J.R., Morris S.E., and Cochran A. Use of inhaled heparin/N-acetylcystine in inhalation injury: does it help?. J. Burn Care Res. 29 (2008) 192-195
20. Hussein A., Meyrick B., Graber S., Berry L., and Brigham K.L. Attenuation of endotoxin-induced cyto-toxicity and prostacyclin production in cultured bovine pulmonary-artery endothelial cells by phosphodiesterase inhibition. Exp. Lung Res. 14 (1988) 637-654
21. Idell S., Kumar A., Zwieb C., Holiday D., Koenig K.B., and Johnson A.R. Effects of TGF-Beta and TNF-Alpha on procoagulant and fibrinolytic pathways of human tracheal epithelial-cells. Am. J. Physiol. Lung Cell Mol. Physiol. 267 (1994) L693-L703
22. Li H.Y., Neill H., Innocent R., Seville P., Williamson I., and Birchall J.C. Enhanced dispersibility and deposition of spray-dried powders for pulmonary gene therapy. J. Drug Target 11 (2003) 425-432
23. Li H.Y., Seville P.C., Williamson I.J., and Birchall J.C. The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy. J. Gene Med. 7 (2005) 343-353
24. Lv Y.G., Liu J., and Zhang J. Theoretical evaluation of burns to the human respiratory tract due to inhalation of hot gas in the early stage of fires. Burns 32 (2006) 436-446
25. Mccall J.E., and Cahill T.J. Respiratory care of the burn patient. J. Burn Care Rehabil. 26 (2005) 200-206
26. Mitchell J.P., and Nagel M.W. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations. J. Aerosol Med. 16 (2003) 341-377
27. Mlcak R.P., Suman O.E., and Herndon D.N. Protective ventilator strategy improves pulmonary function in paediatric patients with inhalation injury. Intens. Care Med. 27 (2001) 501
28. Mlcak R.P., Suman O.E., and Herndon D.N. Respiratory management of inhalation injury. Burns 33 (2007) 2-13
29. Murakami K., Enkhbaatar P., Shimoda K., Mizutani A., Cox R.A., Schmalstieg F.C., Jodoin J.M., Hawkins H.K., Traber L.D., and Traber D.L. High-dose heparin fails to improve acute lung injury following smoke inhalation in sheep. Clin. Sci. 104 (2003) 349-356
30. Murakami K., Mcguire R., Cox R.Q.A., Jodoin J.M., Bjertnaes L.J., Katahira J., Traber L.D., Schmalstieg F.C., Hawkins H.K., Herndon D.N., and Traber D.L. Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep. Shock 18 (2002) 236-241
31. Najafabadi A.R., Gilani K., Barghi M., and Rafiee-Tehrani M. The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine. Int. J. Pharm. 285 (2004) 97-108
32. Ogura H., Cioffi W.G., Okerberg C.V., Johnson A.A., Guzman R.F., Mason A.D., and Pruitt B.A. The effects of pentoxifylline on pulmonary-function following smoke-inhalation. J. Surg. Res. 56 (1994) 242-250
33. Oliveira I.S., Pinheiro B.V., Silva I., Salomao R., Zollner R.L., and Beppu O.S. Pentoxifylline decreases tumor necrosis factor and interleukin-1 during high tidal volume. Braz. J. Med. Biol. Res. 36 (2003) 1349-1357
34. Qi Y.W., Zhao G.L., Liu D.F., Shriver Z., Sundaram M., Sengupta S., Venkataraman G., Langer R., and Sasisekharan R. Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 9867-9872
35. Rabbani N.R., and Seville P.C. The influence of formulation components on the aerosolisation properties of spray-dried powders. J. Control Rel. 110 (2005) 130-140
36. Raula J., Kuivanen A., Laehde A., Jiang H., Antopolsky M., Kansikas J., and Kauppinen E.I. Synthesis of L-leucine nanoparticles via physical vapor deposition at varying saturation conditions. J. Aerosol Sci. 38 (2007) 1172-1184
37. Sacchetti C., Artusi M., Santi P., and Colombo P. Caffeine microparticles for nasal administration obtained by spray drying. Int. J. Pharm. 242 (2002) 335-339
38. Sham J.O.H., Zhang Y., Finlay W.H., Roa W.H., and Lobenberg R. Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung. Int. J. Pharm. 269 (2004) 457-467
39. Shur J., Nevell T.G., Ewen R.J., Price R., Smith A., Barbu E., Conway J.H., Carroll M.P., Shute J.K., and Smith J.R. Cospray-dried unfractionated heparin with l-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapy. J. Pharm. Sci. 97 (2008) 4857-4868
40. Smith I.J., and Parry-Billings M. The inhalers of the future? A review of dry powder devices on the market today. Pul. Pharm. Therap. 16 (2003) 79-95
41. Smyth H.D.C. The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers. Adv. Drug Deliv. Rev. 55 (2003) 807-828
42. Strieter R.M., Remick D.G., Ward P.A., Spengler R.N., Lynch J.P., Larrick J., and Kunkel S.L. Cellular and molecular regulation of tumor necrosis factor-Alpha production by pentoxifylline. Biochem. Biophys. Res. Commun. 155 (1988) 1230-1236
43. Tasaki O., Mozingo D.W., Dubick M.A., Goodwin C.W., Yantis L.D., and Pruitt B.A. Effects of heparin and lisofylline on pulmonary function after smoke inhalation injury in an ovine model. Crit. Care Med. 30 (2002) 637-643